Dual anti-platelet therapy and dento-alveolar surgery. How do we manage patients on anti-platelet medication?

被引:0
|
作者
N. Patel
V. Patel
D. Sarkar
T. Nokes
P. Blacklock
机构
[1] Academic Clinical Fellow in Oral Surgery,Oral Surgery Department
[2] The University of Manchester,undefined
[3] School of Dentistry,undefined
[4] StR Oral Surgery,undefined
[5] Fl 23,undefined
[6] Guys Dental Hospital,undefined
[7] Guys & St Thomas NHS Foundation Trust,undefined
[8] Cons Cardiologist Derriford Hospital,undefined
[9] Plymouth,undefined
[10] PL6 8DH,undefined
[11] Consultant Haematologist Derriford Hospital,undefined
[12] Plymouth,undefined
[13] PL6 8DH,undefined
[14] Associate Specialist Oral and Maxillofacial Surgery,undefined
[15] Derriford Hospital,undefined
[16] Plymouth,undefined
[17] PL6 8DH,undefined
来源
British Dental Journal | 2014年 / 217卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Explains the uses of anti-platelet drugs.Reports variation in the practice of managing these patients.Suggests there is no high quality evidence on how to best manage patients taking dual anti-platelet medication undergoing dentoalveolar surgery.
引用
收藏
页码:E24 / E24
相关论文
共 50 条
  • [21] Anti-platelet therapy: phosphodiesterase inhibitors
    Gresele, Paolo
    Momi, Stefania
    Falcinelli, Emanuela
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 72 (04) : 634 - 646
  • [22] Single Anti-Platelet Therapy versus Dual Anti-Platelet Therapy after Transcatheter Aortic Valve Replacement: A Meta-Analysis
    Abuzaid, Ahmed
    Ranjan, Pragya
    Fabrizio, Carly
    Felpel, Kevin
    Chawla, Raveen
    Topic, Adrienne
    Elgendy, Islam Y.
    STRUCTURAL HEART-THE JOURNAL OF THE HEART TEAM, 2018, 2 (05): : 408 - 418
  • [23] A paradigm shift in anti-platelet therapy?
    Bonello, L.
    Barragan, P.
    Paganelli, F.
    PLATELETS, 2008, 19 (08) : 562 - 564
  • [24] Anti-platelet therapy algorithms in women
    Tkacheva, O. N.
    Kirsanova, T. V.
    Latysheva, N. V.
    CARDIOVASCULAR THERAPY AND PREVENTION, 2011, 10 (01): : 110 - 119
  • [25] Novel agents for anti-platelet therapy
    Ji, Xuebin
    Hou, Ming
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2011, 4
  • [26] Optimizing Anti-Platelet Therapy for Patients with At-Risk Acute Coronary Syndrome The Era of Triple Anti-Platelet Therapy Introduction
    Gibson, C. Michael
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2010, 12 (0D) : D1 - D3
  • [27] Role of Platelet Transfusion in the Reversal of Anti-Platelet Therapy
    Nagalla, Srikanth
    Sarode, Ravi
    TRANSFUSION MEDICINE REVIEWS, 2019, 33 (02) : 92 - 97
  • [28] DO WE NEED SYSTEMIC ANTICOAGULATION AND DUAL ANTI-PLATELET THERAPY FOR FRACTIONAL FLOW RESERVE CALCULATION?
    Dhindsa, Mandeep
    Boccalandro, Fernando
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A1943 - A1943
  • [29] ROLE OF PLATELET TRANSFUSION IN GASTROINTESTINAL BLEEDING IN PATIENTS ON ANTI-PLATELET THERAPY
    Victor, Navin
    Umakanthan, Jayadev
    Gandhi, Apurva
    Nakda, Joseph
    Baber, Aurangzeb
    Patel, Rajeshkumar
    CRITICAL CARE MEDICINE, 2014, 42 (12)
  • [30] ANTI-PLATELET THERAPY IN DIABETIC-PATIENTS WITH RETINOPATHY
    TINDALL, H
    PATON, RC
    MCNICOL, GP
    THROMBOSIS AND HAEMOSTASIS, 1981, 46 (01) : 196 - 196